Comprehensive identification of novel tumor markers by targeted shotgun proteomics
Project/Area Number |
23650612
|
Research Category |
Grant-in-Aid for Challenging Exploratory Research
|
Allocation Type | Multi-year Fund |
Research Field |
Tumor diagnosis
|
Research Institution | Jikei University School of Medicine (2012) Tokyo Medical and Dental University (2011) |
Principal Investigator |
|
Project Period (FY) |
2011 – 2012
|
Project Status |
Completed (Fiscal Year 2012)
|
Budget Amount *help |
¥3,640,000 (Direct Cost: ¥2,800,000、Indirect Cost: ¥840,000)
Fiscal Year 2012: ¥1,690,000 (Direct Cost: ¥1,300,000、Indirect Cost: ¥390,000)
Fiscal Year 2011: ¥1,950,000 (Direct Cost: ¥1,500,000、Indirect Cost: ¥450,000)
|
Keywords | プロテオーム / 癌 / 腫瘍マーカー / プロテオミクス |
Research Abstract |
In an attempt to identify cancer-specific disease markers, we chose 2DICAL as a quantitative proteome analysis. By using 2DICAL, we found novel cancer-related genes.
|
Report
(3 results)
Research Products
(30 results)
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
[Presentation] Amphiregulin, a novel target of p53, modulates microRNA metabolism in the nucleus.2011
Author(s)
Taira N, Kimura J, Lu Z-G, Yamaguchi T, Higashiyama S, Ono M, Miki Y, Yoshida K
Organizer
'Signal Transduction within the Nucleus', Gordon Research Conference.
Place of Presentation
Ventura, CA
Related Report
-
-
-
-
-